View of Cardiovascular risk and JAK inhibitor for the treatment of spondyloarthritis: A systematic review protocol

Return to Article Details Cardiovascular risk and JAK inhibitor for the treatment of spondyloarthritis: A systematic review protocol Download Download PDF